| Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study DJH Moss, AF Pardiñas, D Langbehn, K Lo, BR Leavitt, R Roos, A Durr, ... The Lancet Neurology 16 (9), 701-711, 2017 | 325 | 2017 |
| Skeletal muscle pathology in Huntington's disease D Zielonka, I Piotrowska, JT Marcinkowski, M Mielcarek Frontiers in physiology 5, 380, 2014 | 135 | 2014 |
| The influence of gender on phenotype and disease progression in patients with Huntington's disease D Zielonka, J Marinus, RAC Roos, G De Michele, S Di Donato, H Putter, ... Parkinsonism & related disorders 19 (2), 192-197, 2013 | 126 | 2013 |
| HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements M Mielcarek, D Zielonka, A Carnemolla, JT Marcinkowski, F Guidez Frontiers in cellular neuroscience 9, 42, 2015 | 112 | 2015 |
| Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study R Reilmann, A McGarry, ID Grachev, JM Savola, B Borowsky, E Eyal, ... The Lancet Neurology 18 (2), 165-176, 2019 | 106 | 2019 |
| Update on Huntington's disease: advances in care and emerging therapeutic options D Zielonka, M Mielcarek, GB Landwehrmeyer Parkinsonism & related disorders 21 (3), 169-178, 2015 | 93 | 2015 |
| Przegląd koncepcji jakości życia w naukach społecznych M Wnuk, D Zielonka, B Purandare, A Kaniewski, A Klimberg, ... Hygeia Public Health 48 (1), 10-16, 2013 | 64 | 2013 |
| Clinical manifestations of intermediate allele carriers in Huntington disease E Cubo, MA Ramos-Arroyo, S Martinez-Horta, A Martínez-Descalls, ... Neurology 87 (6), 571-578, 2016 | 56 | 2016 |
| Circadian rhythms of melatonin and cortisol in manifest Huntington’s disease and in acute cortical ischemic stroke A Adamczak-Ratajczak, J Kupsz, M Owecki, D Zielonka, A Sowinska, ... J Physiol Pharmacol 68 (4), 539-546, 2017 | 53 | 2017 |
| An impaired metabolism of nucleotides underpins a novel mechanism of cardiac remodeling leading to Huntington's disease related cardiomyopathy M Toczek, D Zielonka, P Zukowska, JT Marcinkowski, E Slominska, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (11 …, 2016 | 45 | 2016 |
| A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease HORIZON Investigators of the Huntington Study Group, ... JAMA neurology 70 (1), 25-33, 2013 | 42 | 2013 |
| The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease D Zielonka, M Ren, G De Michele, RAC Roos, F Squitieri, AR Bentivoglio, ... Parkinsonism & related disorders 49, 42-47, 2018 | 41 | 2018 |
| A study of molecular changes relating to energy metabolism and cellular stress in people with Huntington’s disease: looking for biomarkers J Krzysztoń-Russjan, D Zielonka, J Jackiewicz, S Kuśmirek, I Bubko, ... Journal of bioenergetics and biomembranes 45, 71-85, 2013 | 40 | 2013 |
| Huntington’disease–imbalance of amino acid levels in plasma of patients and mutation carriers BM Gruber, G Klaczkow, M Jaworska, J Krzyszton-Russjan, ... Annals of Agricultural and Environmental Medicine 20 (4), 2013 | 34 | 2013 |
| Gender differences in non-sex linked disorders: insights from Huntington's disease D Zielonka, B Stawinska-Witoszynska Frontiers in Neurology 11, 571, 2020 | 32 | 2020 |
| Clinical and genetic characteristics of late-onset Huntington's disease M Oosterloo, EK Bijlsma, SM Van Kuijk, F Minkels, CEM de Die-Smulders Parkinsonism & related disorders 61, 101-105, 2019 | 32 | 2019 |
| Validation of the first quality-of-life measurement for patients with Huntington’s disease: the Huntington Quality of Life Instrument E Clay, A De Nicola, J Dorey, F Squitieri, S Aballéa, T Martino, J Tedroff, ... International clinical psychopharmacology 27 (4), 208-214, 2012 | 27 | 2012 |
| Association of influenza incidence with multiple sclerosis onset R Kaźmierski, M Wender, P Guzik, D Zielonka Folia Neuropathol 42 (1), 19-23, 2004 | 25 | 2004 |
| Cardiac dysfunction in Huntington’s disease D Zielonka, I Piotrowska, M Mielcarek Exp Clin Cardiol 20 (8), 2547-54, 2014 | 24 | 2014 |
| Prevalence of non-psychiatric comorbidities in pre-symptomatic and symptomatic Huntington's disease gene carriers in Poland D Zielonka, G Witkowski, EA Puch, M Lesniczak, I Mazur-Michalek, ... Frontiers in Medicine 7, 79, 2020 | 16 | 2020 |
Michal MielcarekImperial College london在 imperial.ac.uk 的电子邮件经过验证
